ArticleCureus2026
A Survey on the Current Status of Joubert Syndrome and Related Disorders Conducted Through a Patient and Family Group in Japan.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Joubert syndrome and related disorders (JSRD) are rare and intractable diseases characterized by delayed psychomotor development, hypotonia and/or ataxia, and abnormal respiratory and eye movements. The Patient and Family Advocacy Group for Joubert Syndrome and Related Disorders in Japan was established in 2016. Since its inception, meetings for patients and families have been held approximately once a year. Methods An advocacy group meeting was held at our facility, consisting of a medical lecture and an open forum for information exchange among patients and families. A post-meeting questionnaire was administered to assess the needs and current circumstances of patients and families. Results Many patients were enrolled in or had attended special needs schools or received individualized educational accommodations. All patients had previously received rehabilitation therapy, with a significant proportion continuing therapy at the time of the survey. Families indicated a strong need for information on a range of topics, including medical care, social welfare, and education. Conclusions Addressing the ongoing needs of patients and families with rare and intractable diseases in the areas of healthcare, research, and support system remains a continuing challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.